News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InterGenetics Incorporated Release: U.S. Commercial Market Widens for Distribution of First Multi-Factor Genetics-Based Breast Cancer Risk Test



8/4/2008 9:52:47 AM

OKLAHOMA CITY--(BUSINESS WIRE)--InterGenetics®, a personalized medicine company focused on molecular diagnostics and targeted therapy for cancer, announced the addition of fourteen new clinical sites in nine new states for the distribution of OncoVue, the first broadly applicable genetics-based breast cancer risk test. OncoVue incorporates both gene-based information and personal history measures to determine a woman’s future risk of developing breast cancer.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES